Concentrix (CNXC) Insider Sells 500 Shares at $47.08
Twomey Cormac J, Executive Vice President, Global Ops & Delivery at Concentrix Corp (CNXC), reported a sale of 500 shares of the issuer's common stock on 09/30/2025 at a price of $47.08 per share.
Rhea-AI Filing Summary
Twomey Cormac J, Executive Vice President, Global Ops & Delivery at Concentrix Corp (CNXC), reported a sale of 500 shares of the issuer's common stock on 09/30/2025 at a price of $47.08 per share. The filing states the sale was effected pursuant to a Rule 10b5-1 trading plan established on January 28, 2025. After the reported transaction the reporting person beneficially owns 36,130 shares, held directly. The Form 4 was filed as a single-person filing and bears an attorney-in-fact signature dated 10/02/2025.
Positive
- Sale executed under a Rule 10b5-1 trading plan established Jan 28, 2025
- Reporting person retains 36,130 direct shares after the transaction
Negative
- None.
Insights
TL;DR: A routine insider sale under a pre-arranged 10b5-1 plan: 500 shares sold at $47.08.
The transaction was executed under a Rule 10b5-1 trading plan established on January 28, 2025, which indicates the sale was preplanned rather than opportunistic. The reporting person retained 36,130 shares following the sale, and ownership is reported as direct.
This filing contains only the single disclosed sale and does not include options, purchases, or other derivative activity. The signature was provided by an attorney-in-fact on 10/02/2025, consistent with routine administrative execution.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 500 | $47.08 | $24K |
Footnotes (1)
- F1. This sale was effected pursuant to a Rule 10b5-1 trading plan by the reporting person on January 28, 2025.
FAQ
Who reported the transaction for CNXC?
Was the sale part of a pre-arranged trading plan for CNXC insiders?
When was the Form 4 signed and who signed it?
AI-generated analysis. How Rhea-AI works. Not financial advice.